Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07039669 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Name: Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease — clinical trial record (NCT07039669)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Started2025-07-16

View on ClinicalTrials.gov ↗

Amendment history

2025-11-17

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2025-07→confirmed 2025-07-16

Study sitesdetails revised at 4 of 4 sites

2025-06-30

Study Status, Outcome Measures v1

Secondary endpointsdetails revised at 1 of 12 entries

2025-06-17

Original filing

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

22 trials monitored

See all monitored trials

COPD

1,057 trials monitored

See 28 trials at risk

The objective of the study was to evaluate the efficacy and safety of 611 in Chinese adults with moderate to severe COPD.

Trial Details

NCT Number	NCT07039669
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Pulmonary Disease, Chronic Obstructive (COPD)
Enrollment	594 participants
Start Date	2025-07-16
Primary Completion	2028-09 (estimated)
Study Completion	2028-11 (estimated)
Updated on ClinicalTrials.gov	2025-11-18